Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Claude Hofmann

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Endocrinology|July 12, 2023
Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistanceSarah Hamidi, Marie-Claude Hofmann, Priyanka C Iyer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 18, 2019
Undifferentiated spermatogonia regulate <i>Cyp26b1</i> expression through NOTCH signaling and drive germ cell differentiationParag A Parekh, Thomas X Garcia, Reham Waheeb, et al.
Oncotarget|April 30, 2016
Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma modelBrian P Danysh, Erin Y Rieger, Deepankar K Sinha, et al.
Annals of the New York Academy of Sciences|October 4, 2007
ETV5 is required for continuous spermatogenesis in adult mice and may mediate blood testes barrier function and testicular immune privilegeCarla M K Morrow, Chris E Hostetler, Mike D Griswold, et al.
Molecular Cancer Research : MCR|May 23, 2023
Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2Hannah M Hicks, Nikita Pozdeyev, Sharon B Sams, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 22, 2010
Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cellsLaura K Braydich-Stolle, Benjamin Lucas, Amanda Schrand, et al.
Endocrine-Related Cancer|August 17, 2022
Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancersMarie-Claude Hofmann, Muthusamy Kunnimalaiyaan, Jennifer R Wang, et al.
Oncogenesis|March 1, 2018
Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancerThomas C Beadnell, Kelsey W Nassar, Madison M Rose, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2013
Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paragangliomaMontserrat Ayala-Ramirez, J Lynn Palmer, Marie-Claude Hofmann, et al.
Stem Cells (Dayton, Ohio)|August 28, 2010
ETV5 regulates sertoli cell chemokines involved in mouse stem/progenitor spermatogonia maintenanceLiz Simon, Gail C Ekman, Thomas Garcia, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Endocrinology|July 12, 2023
Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistanceSarah Hamidi, Marie-Claude Hofmann, Priyanka C Iyer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 18, 2019
Undifferentiated spermatogonia regulate <i>Cyp26b1</i> expression through NOTCH signaling and drive germ cell differentiationParag A Parekh, Thomas X Garcia, Reham Waheeb, et al.
Oncotarget|April 30, 2016
Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma modelBrian P Danysh, Erin Y Rieger, Deepankar K Sinha, et al.
Annals of the New York Academy of Sciences|October 4, 2007
ETV5 is required for continuous spermatogenesis in adult mice and may mediate blood testes barrier function and testicular immune privilegeCarla M K Morrow, Chris E Hostetler, Mike D Griswold, et al.
Molecular Cancer Research : MCR|May 23, 2023
Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2Hannah M Hicks, Nikita Pozdeyev, Sharon B Sams, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 22, 2010
Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cellsLaura K Braydich-Stolle, Benjamin Lucas, Amanda Schrand, et al.
Endocrine-Related Cancer|August 17, 2022
Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancersMarie-Claude Hofmann, Muthusamy Kunnimalaiyaan, Jennifer R Wang, et al.
Oncogenesis|March 1, 2018
Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancerThomas C Beadnell, Kelsey W Nassar, Madison M Rose, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2013
Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paragangliomaMontserrat Ayala-Ramirez, J Lynn Palmer, Marie-Claude Hofmann, et al.
Stem Cells (Dayton, Ohio)|August 28, 2010
ETV5 regulates sertoli cell chemokines involved in mouse stem/progenitor spermatogonia maintenanceLiz Simon, Gail C Ekman, Thomas Garcia, et al.
Pageof 8